Trial intelligence / Profile preview

Modified Tianwang Buxin for Insomnia (Granule vs Decoction Pieces)

ChiCTR-IPR-17011549Phase 4Recruiting

Sponsor
Hubei Provincial Traditional Chinese Medical Hospital
Start
Jun 2017
Countries
1
01

Overview

Phase 4, randomised trial of modified Tianwang Buxin prescription in Insomnia (2 arms), sponsored by Hubei Provincial Traditional Chinese Medical Hospital. Primary endpoints: Traditional Chinese Medicine (TCM) syndrome score, Pittsburgh Sleep Quality Index (PSQI) and 7 more. Started Jun 2017; status: recruiting.

02

Drugs

modified Tianwang Buxin prescription
03

Conditions

Insomnia

Beyond the preview

Go deeper on ChiCTR-IPR-17011549.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-17011549.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call